Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Colon & Rectum (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 21.7 (21.6, 21.7) N/A 81,622 59.1
Mississippi 6 28.6 (27.8, 29.4) 1 (1, 1) 1,013 61.2
West Virginia 6 25.8 (24.9, 26.7) 2 (2, 7) 641 58.1
Louisiana 3 25.8 (25.2, 26.4) 3 (2, 7) 1,404 58.1
Kentucky 3 25.6 (25.0, 26.2) 4 (2, 7) 1,381 55.5
Arkansas 6 25.6 (24.8, 26.3) 5 (2, 8) 940 60.2
Alaska 6 25.0 (23.3, 26.8) 6 (2, 19) 181 60.8
South Dakota 6 24.7 (23.3, 26.1) 7 (2, 18) 258 61.5
Missouri 6 24.2 (23.6, 24.7) 8 (6, 15) 1,815 62.1
Illinois 3 24.1 (23.8, 24.5) 9 (6, 14) 3,641 60.4
Tennessee 6 23.8 (23.4, 24.3) 10 (6, 16) 1,949 60.8
Pennsylvania 6 23.8 (23.4, 24.1) 11 (7, 16) 3,992 61.8
Ohio 6 23.7 (23.3, 24.1) 12 (7, 16) 3,448 60.3
North Dakota 6 23.4 (22.0, 25.0) 13 (3, 27) 201 60.3
Iowa 3 23.3 (22.6, 24.0) 14 (7, 20) 899 57.0
Nebraska 6 23.3 (22.4, 24.3) 15 (6, 23) 515 57.2
Kansas 6 23.0 (22.3, 23.8) 16 (8, 23) 774 58.5
Alabama 6 22.7 (22.2, 23.3) 17 (12, 23) 1,366 54.9
Oklahoma 6 22.4 (21.8, 23.1) 18 (14, 26) 1,022 56.2
New Jersey 3 22.4 (22.0, 22.8) 19 (15, 24) 2,466 57.8
Georgia 3 22.2 (21.8, 22.6) 20 (16, 25) 2,570 56.5
Hawaii 3 22.1 (21.1, 23.2) 21 (12, 34) 397 56.8
Montana 6 22.1 (21.0, 23.3) 22 (10, 36) 301 60.7
Texas 3 21.9 (21.7, 22.2) 23 (18, 26) 6,413 59.4
Idaho 3 21.8 (20.9, 22.8) 24 (14, 36) 434 62.9
North Carolina 6 21.5 (21.1, 21.8) 25 (21, 32) 2,661 61.2
Wisconsin 6 21.4 (20.9, 21.9) 26 (21, 34) 1,536 60.8
South Carolina 6 21.2 (20.7, 21.8) 27 (22, 36) 1,347 59.4
Florida 6 21.1 (20.8, 21.3) 28 (24, 35) 6,180 59.1
Michigan 6 21.1 (20.7, 21.5) 29 (24, 36) 2,619 59.0
Wyoming 6 20.9 (19.3, 22.5) 30 (14, 45) 143 59.6
New York 3 20.9 (20.6, 21.1) 31 (26, 36) 4,987 56.7
New Hampshire 6 20.8 (19.9, 21.9) 32 (19, 41) 369 59.3
Minnesota 6 20.6 (20.1, 21.2) 33 (25, 39) 1,360 56.9
Maryland 6 20.6 (20.2, 21.1) 34 (26, 39) 1,472 58.4
Maine 6 20.6 (19.6, 21.6) 35 (21, 42) 387 57.8
Delaware 6 20.5 (19.4, 21.7) 36 (20, 44) 257 58.7
Washington 5 20.4 (20.0, 20.9) 37 (29, 40) 1,745 59.8
Oregon 6 19.8 (19.3, 20.4) 38 (33, 43) 1,013 60.0
Virginia 6 19.8 (19.4, 20.2) 39 (35, 42) 1,966 58.7
Rhode Island 6 19.5 (18.5, 20.7) 40 (26, 48) 258 58.7
California 3 19.4 (19.2, 19.6) 41 (38, 44) 8,445 57.6
Colorado 6 19.1 (18.6, 19.6) 42 (38, 46) 1,178 61.5
Vermont 6 18.6 (17.3, 20.1) 43 (32, 49) 156 55.5
Connecticut 3 18.5 (18.0, 19.1) 44 (40, 48) 848 55.0
New Mexico 3 18.5 (17.7, 19.3) 45 (39, 48) 470 55.8
District of Columbia 6 18.4 (17.0, 20.0) 46 (32, 49) 125 52.8
Massachusetts 3 18.2 (17.8, 18.7) 47 (42, 48) 1,534 56.1
Arizona 6 18.0 (17.6, 18.4) 48 (43, 48) 1,571 57.9
Utah 3 16.7 (16.0, 17.4) 49 (48, 49) 461 57.8
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Puerto Rico 6 18.6 (18.0, 19.3) N/A 768 48.6
Notes:
Created by statecancerprofiles.cancer.gov on 05/20/2024 12:10 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada, Puerto Rico

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top